Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Challenges related to developing serum-based biomarkers for early ovarian cancer detection.

Mai PL, Wentzensen N, Greene MH.

Cancer Prev Res (Phila). 2011 Mar;4(3):303-6. doi: 10.1158/1940-6207.CAPR-11-0053.

PMID:
21372029
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The sine qua non of discovering novel biomarkers for early detection of ovarian cancer: carefully selected preclinical samples.

Jacobs I, Menon U.

Cancer Prev Res (Phila). 2011 Mar;4(3):299-302. doi: 10.1158/1940-6207.CAPR-11-0048.

PMID:
21372028
[PubMed - indexed for MEDLINE]
3.

Personalizing CA125 levels for ovarian cancer screening.

Dorigo O, Berek JS.

Cancer Prev Res (Phila). 2011 Sep;4(9):1356-9. doi: 10.1158/1940-6207.CAPR-11-0378.

PMID:
21893498
[PubMed - indexed for MEDLINE]
4.

Genome-scale screen for DNA methylation-based detection markers for ovarian cancer.

Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, Roman LD, Berchuck A, Pearce CL, Laird PW.

PLoS One. 2011;6(12):e28141. doi: 10.1371/journal.pone.0028141. Epub 2011 Dec 7.

PMID:
22163280
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Protein biomarkers of ovarian cancer: the forest and the trees.

Nolen BM, Lokshin AE.

Future Oncol. 2012 Jan;8(1):55-71. doi: 10.2217/fon.11.135. Review.

PMID:
22149035
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

DNA methylation based biomarkers in non-invasive cancer screening.

Shivapurkar N, Gazdar AF.

Curr Mol Med. 2010 Mar;10(2):123-32. Review.

PMID:
20196733
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

An overview of biomarkers for the ovarian cancer diagnosis.

Zhang B, Cai FF, Zhong XY.

Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):119-23. doi: 10.1016/j.ejogrb.2011.04.023. Epub 2011 May 31. Review.

PMID:
21632171
[PubMed - indexed for MEDLINE]
8.

The quest for ovarian cancer screening biomarkers: are we on the right road?

Lokshin AE.

Int J Gynecol Cancer. 2012 May;22 Suppl 1:S35-40. doi: 10.1097/IGC.0b013e318251ccaa.

PMID:
22543919
[PubMed - indexed for MEDLINE]
9.

Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer.

Gogoi R, Srinivasan S, Fishman DA.

Expert Rev Mol Diagn. 2006 Jul;6(4):627-37. Review.

PMID:
16824035
[PubMed - indexed for MEDLINE]
10.

Update on ovarian cancer screening.

Munkarah A, Chatterjee M, Tainsky MA.

Curr Opin Obstet Gynecol. 2007 Feb;19(1):22-6. Review.

PMID:
17218847
[PubMed - indexed for MEDLINE]
11.

Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.

Hensley ML, Robson ME, Kauff ND, Korytowsky B, Castiel M, Ostroff J, Hurley K, Hann LE, Colon J, Spriggs D.

Gynecol Oncol. 2003 Jun;89(3):440-6.

PMID:
12798709
[PubMed - indexed for MEDLINE]
12.

Diagnostic markers for early detection of ovarian cancer.

Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-Saaib R, Yu H, Azori M, Rutherford T, Schwartz PE, Mor G.

Clin Cancer Res. 2008 Feb 15;14(4):1065-72. doi: 10.1158/1078-0432.CCR-07-1569. Epub 2008 Feb 7. Erratum in: Clin Cancer Res. 2008 Aug 15;14(16):5308. Clin Cancer Res. 2008 Nov 1;14(21):7158.

PMID:
18258665
[PubMed - indexed for MEDLINE]
Free Article
13.

Searching for a system: the quest for ovarian cancer biomarkers.

Rodland KD, Maihle NJ.

Cancer Biomark. 2010-2011;8(4-5):223-30. doi: 10.3233/CBM-2011-0216. Review.

PMID:
22045355
[PubMed - indexed for MEDLINE]
14.

Discovery and application of protein biomarkers for ovarian cancer.

Gagnon A, Ye B.

Curr Opin Obstet Gynecol. 2008 Feb;20(1):9-13. doi: 10.1097/GCO.0b013e3282f226a5. Review.

PMID:
18196999
[PubMed - indexed for MEDLINE]
15.

Proteomics and biomarkers for ovarian cancer diagnosis.

Zhang B, Barekati Z, Kohler C, Radpour R, Asadollahi R, Holzgreve W, Zhong XY.

Ann Clin Lab Sci. 2010 Summer;40(3):218-25. Review.

PMID:
20689132
[PubMed - indexed for MEDLINE]
16.

Contemporary progress in ovarian cancer screening.

Walsh CS, Karlan BY.

Curr Oncol Rep. 2007 Nov;9(6):485-93. Review.

PMID:
17991357
[PubMed - indexed for MEDLINE]
17.

Prevention and early detection of ovarian cancer: mission impossible?

Bast RC Jr, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, Lu K, Lu Z, Badgwell D, Mills GB, Skates S, Zhang Z, Chan D, Lokshin A, Yu Y.

Recent Results Cancer Res. 2007;174:91-100. Review.

PMID:
17302189
[PubMed - indexed for MEDLINE]
18.

Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.

Jurisicova A, Jurisica I, Kislinger T.

Expert Rev Proteomics. 2008 Aug;5(4):551-60. doi: 10.1586/14789450.5.4.551. Review.

PMID:
18761466
[PubMed - indexed for MEDLINE]
19.

Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.

Simon I, Liu Y, Krall KL, Urban N, Wolfert RL, Kim NW, McIntosh MW.

Gynecol Oncol. 2007 Jul;106(1):112-8. Epub 2007 May 8.

PMID:
17490732
[PubMed - indexed for MEDLINE]
20.

Advanced ovarian cancer. Tumour markers.

Rustin GJ, van der Burg ME, Berek JS.

Ann Oncol. 1993;4 Suppl 4:71-7. Review.

PMID:
8312203
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk